UBS Group AG - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 75 filers reported holding KEMPHARM INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$90,336
-11.8%
18,742
-6.7%
0.00%
Q2 2023$102,469
+350.1%
20,092
+385.4%
0.00%
Q1 2023$22,765
-29.0%
4,139
-40.7%
0.00%
Q4 2022$32,043
+434.0%
6,981
+614.5%
0.00%
Q3 2022$6,000
-76.9%
977
-83.1%
0.00%
Q2 2022$26,000
-71.7%
5,798
-44.8%
0.00%
Q4 2021$92,000
-24.6%
10,499
-21.0%
0.00%
Q1 2021$122,00013,2830.00%
Other shareholders
KEMPHARM INC shareholders Q2 2022
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders